Atrial fibrillation as a risk factor for stroke recurrence

American Journal of Medicine

Volumn 114, Issue 3, 2003, Pages 206-210

  Penado, Susana ^a   Cano, Marta ^a   Acha, Olga ^a   Hernández, José L ^a   Riancho, José A ^a,b  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; AGING; ALCOHOL CONSUMPTION; ANTICOAGULATION; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEALTH HAZARD; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 0037440672     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(02)01479-1     Document Type: Article

References (18)

1. Hart R.G., Benavente O., McBride R., Pearce L.A. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation a meta-analysis . Ann Intern Med. 131:1999;492-501.
2. Go A.S., Hylek E.M., Phillips K.A., et al. Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation. The Anticoagulation Risk Factors in Atrial Fibrillation (Atria) Study. Circulation. 102:2000;11-13.
3. Pearce L.A., Hart R.G., Halperin J.L. Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation. Am J Med. 109:2000;45-51.
4. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet. 342:1993;1255-1262.
5. Ezekowitz M.D., Bridgers S.L., James K.E., et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med. 327:1992;1406-1412.
6. Lai S.M., Alter S.M., Friday M., Sobel G.E. A multifactorial analysis of risk factors for recurrence of ischemic stroke. Stroke. 25:1994;958-962.
7. Jorgensen H.S., Nakayama H., Reith J., et al. Stroke recurrence predictors, severity, and prognosis. The Copenhagen Stroke Study . Neurology. 48:1997;891-895.
8. Sacco R.L., Shi T., Zamanillo M.C., Kargman D.E. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community the Northern Manhattan Stroke Study . Neurology. 44:1994;626-634.
9. Kaarisalo M., Immonen-Raiha P., Marttila R.J., et al. Atrial fibrillation in older stroke patients association with stroke recurrence and mortality after first ischemic stroke . J Am Geriatr Soc. 45:1997;1297-1301.
10. Petty G.W., Brown R.D. Jr, Whisnant J.P., et al. Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989. Neurology. 50:1998;208-216.
11. Prencipe M., Culasso F., Rasura M., et al. Long-term prognosis after a minor stroke. 10-year mortality and major stroke recurrence rates in a hospital-based cohort. Stroke. 29:1998;126-132.
12. Gustafsson C., Britton M. Pathogenetic mechanism of stroke in non-valvular atrial fibrillation: follow-up of stroke patients with and without atrial fibrillation. J Intern Med. 230:1991;11-16.
13. Hankey G.J., Slattery J.M., Warlow C.P. The prognosis of hospital-referred transient ischaemic attacks. J Neurol Neurosurg Psychiatry. 4:1991;793-802.
14. Hart R.G., Boop B.S., Anderson D.C. Oral anticoagulants and intracranial hemorrhage. Facts and hypothesis. Stroke. 26:1995;1471-1477.
15. Palareti G., Leali N., Coccheri S., et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet. 348:1996;423-428.
16. Landefeld C.S., Beyth R.J. Anticoagulant-related bleeding: clinical epidemiology, prediction and prevention. Am J Med. 95:1993;315-328.
17. Evans A., Perez I., Yu G., Kalra L. Secondary stroke prevention in atrial fibrillation. Lessons from clinical practice. Stroke. 32:2000;2106-2121.
18. Kalra L., Yu G., Perez I., et al. Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness. BMJ. 320:2000;1236-1239.